KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Short-term Investments (2016 - 2017)

Historic Short-term Investments for Idexx Laboratories (IDXX) over the last 6 years, with Q4 2017 value amounting to $284.3 million.

  • Idexx Laboratories' Short-term Investments rose 1996.46% to $284.3 million in Q4 2017 from the same period last year, while for Dec 2017 it was $284.3 million, marking a year-over-year increase of 1996.46%. This contributed to the annual value of $284.3 million for FY2017, which is 1996.46% up from last year.
  • According to the latest figures from Q4 2017, Idexx Laboratories' Short-term Investments is $284.3 million, which was up 1996.46% from $285.1 million recorded in Q3 2017.
  • Idexx Laboratories' Short-term Investments' 5-year high stood at $285.1 million during Q3 2017, with a 5-year trough of $453000.0 in Q1 2014.
  • Its 5-year average for Short-term Investments is $145.5 million, with a median of $208.4 million in 2015.
  • As far as peak fluctuations go, Idexx Laboratories' Short-term Investments tumbled by 9007.23% in 2014, and later skyrocketed by 3063178.81% in 2015.
  • Quarter analysis of 5 years shows Idexx Laboratories' Short-term Investments stood at $1.1 million in 2013, then surged by 910.47% to $10.9 million in 2014, then soared by 1859.01% to $213.6 million in 2015, then rose by 10.94% to $236.9 million in 2016, then increased by 19.96% to $284.3 million in 2017.
  • Its last three reported values are $284.3 million in Q4 2017, $285.1 million for Q3 2017, and $256.9 million during Q2 2017.